203 related articles for article (PubMed ID: 23001705)
81. The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy.
Shen DF; Liu X; Yang XF; Fang L; Gao Y; Zhao S; Wu JC; Shi S; Li JJ; Zhao XX; Gou WF; Zheng HC
Tumour Biol; 2016 Mar; 37(3):2909-24. PubMed ID: 26409451
[TBL] [Abstract][Full Text] [Related]
82. Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases.
Erickson LA; Jin L; Papotti M; Lloyd RV
Am J Surg Pathol; 2002 Mar; 26(3):344-9. PubMed ID: 11859206
[TBL] [Abstract][Full Text] [Related]
83. Angiogenesis and lymphangiogenesis in parathyroid proliferative lesions.
Garcia de la Torre N; Buley I; Wass JA; Jackson DG; Turner HE
J Clin Endocrinol Metab; 2004 Jun; 89(6):2890-6. PubMed ID: 15181073
[TBL] [Abstract][Full Text] [Related]
84. Targets for molecular therapy in esophageal squamous cell carcinoma: an immunohistochemical analysis.
Boone J; van Hillegersberg R; Offerhaus GJ; van Diest PJ; Borel Rinkes IH; Ten Kate FJ
Dis Esophagus; 2009; 22(6):496-504. PubMed ID: 19302210
[TBL] [Abstract][Full Text] [Related]
85. Identification of differentially expressed microRNA in parathyroid tumors.
Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
[TBL] [Abstract][Full Text] [Related]
86. Evaluation of malignant parathyroid tumours in two European cohorts of patients with sporadic primary hyperparathyroidism.
Ozolins A; Narbuts Z; Vanags A; Simtniece Z; Visnevska Z; Akca A; Wirowski D; Gardovskis J; Strumfa I; Goretzki PE
Langenbecks Arch Surg; 2016 Nov; 401(7):943-951. PubMed ID: 26658808
[TBL] [Abstract][Full Text] [Related]
87. Reduced vitamin D receptor expression in parathyroid adenomas: implications for pathogenesis.
Sudhaker Rao D; Han ZH; Phillips ER; Palnitkar S; Parfitt AM
Clin Endocrinol (Oxf); 2000 Sep; 53(3):373-81. PubMed ID: 10971456
[TBL] [Abstract][Full Text] [Related]
88. Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway.
Li SH; Fu J; Watkins DN; Srivastava RK; Shankar S
Mol Cell Biochem; 2013 Jan; 373(1-2):217-27. PubMed ID: 23129257
[TBL] [Abstract][Full Text] [Related]
89. Mesenchymal chondrosarcoma: molecular characterization by a proteomic approach, with morphogenic and therapeutic implications.
Brown RE; Boyle JL
Ann Clin Lab Sci; 2003; 33(2):131-41. PubMed ID: 12817616
[TBL] [Abstract][Full Text] [Related]
90. Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.
Richtig G; Aigelsreiter AM; Asslaber M; Weiland T; Pichler M; Eberhard K; Sygulla S; Schauer S; Hoefler G; Aigelsreiter A
Histopathology; 2019 Jul; 75(1):118-127. PubMed ID: 30861166
[TBL] [Abstract][Full Text] [Related]
91. A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer.
Cetani F; Pardi E; Viacava P; Pollina GD; Fanelli G; Picone A; Borsari S; Gazzerro E; Miccoli P; Berti P; Pinchera A; Marcocci C
Clin Endocrinol (Oxf); 2004 Jan; 60(1):99-106. PubMed ID: 14678295
[TBL] [Abstract][Full Text] [Related]
92. Analysis of parathyroid neoplasms by interphase fluorescence in situ hybridization.
Erickson LA; Jalal SM; Harwood A; Shearer B; Jin L; Lloyd RV
Am J Surg Pathol; 2004 May; 28(5):578-84. PubMed ID: 15105644
[TBL] [Abstract][Full Text] [Related]
93. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages.
Silva-Figueroa A; Villalobos P; Williams MD; Bassett RL; Clarke CN; Lee JE; Busaidy NL; Perrier ND
Surgery; 2018 Nov; 164(5):960-964. PubMed ID: 30033186
[TBL] [Abstract][Full Text] [Related]
94. Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.
Silvestrini R; Veneroni S; Benini E; Daidone MG; Luisi A; Leutner M; Maucione A; Kenda R; Zucali R; Veronesi U
J Natl Cancer Inst; 1997 May; 89(9):639-45. PubMed ID: 9150188
[TBL] [Abstract][Full Text] [Related]
95. Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment.
Cetani F; Pardi E; Ambrogini E; Banti C; Viacava P; Borsari S; Bilezikian JP; Pinchera A; Marcocci C
J Endocrinol Invest; 2008 Oct; 31(10):900-4. PubMed ID: 19092296
[TBL] [Abstract][Full Text] [Related]
96. Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma.
Hegde GV; Munger CM; Emanuel K; Joshi AD; Greiner TC; Weisenburger DD; Vose JM; Joshi SS
Mol Cancer Ther; 2008 Jun; 7(6):1450-60. PubMed ID: 18524848
[TBL] [Abstract][Full Text] [Related]
97. Parathyroid Neoplasms: Immunohistochemical Characterization and Long Noncoding RNA (lncRNA) Expression.
Yu Q; Hardin H; Chu YH; Rehrauer W; Lloyd RV
Endocr Pathol; 2019 Jun; 30(2):96-105. PubMed ID: 31119524
[TBL] [Abstract][Full Text] [Related]
98. Role of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms.
Kumari N; Chaudhary N; Pradhan R; Agarwal A; Krishnani N
Endocr Pathol; 2016 Jun; 27(2):87-96. PubMed ID: 26984237
[TBL] [Abstract][Full Text] [Related]
99. Beta-catenin activation is not involved in sporadic parathyroid carcinomas and adenomas.
Cetani F; Pardi E; Banti C; Collecchi P; Viacava P; Borsari S; Fanelli G; Naccarato AG; Saponaro F; Berti P; Miccoli P; Pinchera A; Marcocci C
Endocr Relat Cancer; 2010 Mar; 17(1):1-6. PubMed ID: 19755524
[TBL] [Abstract][Full Text] [Related]
100. Expression of the sonic hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy.
Nelson KK; Gattuso P; Xu X; Prinz RA
Surgery; 2010 Oct; 148(4):654-60; discussion 660. PubMed ID: 20797751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
